Our long-acting injectable (LAI) programs are carefully designed with the optimal combination of duration of action, drug loading content and particle size to address the precise needs for each therapeutic indications of unmet needs. Each drug candidate is selected to demonstrate superiority to current standard of care in efficacy, safety and convenience. We adopt a portfolio approach with the aim to cure a specific disease with multiple lines of treatments, combination therapies, and complementary product features.
